TABLE 3:
Percentage improvement in clinical signs of flea allergy dermatitis (FAD) in the multicentre European field study
| Clinical sign |
||||||
|---|---|---|---|---|---|---|
| Treatment | Pruritus | Papules | Erythema | Alopecia | Scaling | Dermatitis/pyodermatitis |
| Spinosad | ||||||
| No. of cats with score >0 at day 0)* | 71 | 25 | 30 | 26 | 41 | 20 |
| No. of cats with improved score at day 60)† | 68 | 25 | 29 | 26 | 38 | 19 |
| Improvement (%)‡ | 95.8 | 100.0 | 96.7 | 100.0 | 92.7 | 95.0 |
| Selamectin (stronghold) | ||||||
| No. of cats with score >0 at day 0)* | 53 | 25 | 22 | 11 | 27 | 16 |
| No. of cats with improved score at day 60)† | 48 | 23 | 21 | 9 | 22 | 15 |
| Improvement (%)‡ | 90.6 | 92.0 | 95.5 | 81.8 | 81.5 | 93.8 |
*For each clinical sign, the number of cats that had a score >0 for that sign at the first clinic visit (study day 0) that were included in the evaluation of efficacy and were within the overall FAD population
†For each clinical sign, the number of cats that had a score >0 for that sign at the first clinic visit (study day 0) and that had an improved score for that sign at the fourth clinic visit (study day 60)
‡For each clinical sign, the percentage of those cats that had a score >0 for that sign at the first clinic visit (study day 0) and that had an improved score for that sign at the fourth clinic visit (study day 60)